Abstract
Tests of cell mediated immunity (one and two stage leucocyte migration inhibition assays) and humoural immunity (membrane immunofluorescence and serum effects on leucocyte migration) were done with leucocytes and sera from 36 patients with uveal melanoma, five with conjunctival melanoma, 21 with non-malignant ocular disease, and 189 with cutaneous melanoma. Cell mediated reactivity with melanoma extracts and serum reactivity with cultured melanoma cells were significantly more frequent in the melanoma patients, but control donor reactivity was also relatively high. Maximum reactivity was found with cells or serum from those patients in whom, on pathological examination, the intraocular melanoma had penetrated the sclera and in patients with conjunctival melanoma. Maximum separation of melanoma patients from control donors was achieved by consideration of the results of several tests done simultaneously. These immunopathological studies were made during the period from 1972 to 1978. At follow-up in 1983 four of the five patients suffering from conjunctival melanoma had died from metastases, and 10 of the 36 with uveal melanoma had died from metastatic disease. The immunological reactions, while of some value in separating melanoma patients from those without melanoma, did not predict whether a particular patient with uveal melanoma would die of metastatic disease or would survive.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bendixen G., Soborg M. A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan Med Bull. 1969 Jan;16(1):1–6. [PubMed] [Google Scholar]
- Char D. H. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors. Invest Ophthalmol Vis Sci. 1977 Feb;16(2):176–179. [PubMed] [Google Scholar]
- Char D. H., Jerome L., McCoy J. L., Herberman R. B. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma. Am J Ophthalmol. 1975 May;79(5):812–816. doi: 10.1016/0002-9394(75)90741-2. [DOI] [PubMed] [Google Scholar]
- Cochran A. J., Mackie R. M., Ross C. E., Ogg L. J., Jackson A. M. Leukocyte migration inhibition by cancer patients' sera. Int J Cancer. 1976 Sep 15;18(3):274–281. doi: 10.1002/ijc.2910180303. [DOI] [PubMed] [Google Scholar]
- Felberg N. T., Donoso L. A., Federman J. L. Tumor-associated antibodies in the serum of patients with ocular melanoma. IV. Correction for smooth muscle antibodies. Ophthalmology. 1980 Jun;87(6):529–533. doi: 10.1016/s0161-6420(80)35210-x. [DOI] [PubMed] [Google Scholar]
- Felberg N. T., Pro-Landazuri J. M., Shields J. A., Federman J. L. Tumor-associated antibodies in the serum of patients with ocular melanoma. III. Immunoperoxidase detection. Arch Ophthalmol. 1979 Feb;97(2):256–259. doi: 10.1001/archopht.1979.01020010108002. [DOI] [PubMed] [Google Scholar]
- Manor R. S., Livni E., Joshua H., Ben-Sira I. Inhibition of macrophage migration by choroidal malignant melanoma-associated antigens in patients with unveal melanoma. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):684–687. [PubMed] [Google Scholar]
- Morrison L. J., Cochran A. J., Mackie R. M., Ross C. E., Todd G., Garland C., Garland G. Indirect leukocyte migration assay in patients with malignant melanoma. Int J Cancer. 1979 Jul 15;24(1):11–16. doi: 10.1002/ijc.2910240104. [DOI] [PubMed] [Google Scholar]
- Rahi A. H. Autoimmune reactions in uveal melanoma. Br J Ophthalmol. 1971 Dec;55(12):793–807. doi: 10.1136/bjo.55.12.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross C. E., Cochran A. J., Hoyle D. E., Grant R. M., Mackie R. M. Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol. 1975 Oct;22(1):126–132. [PMC free article] [PubMed] [Google Scholar]
- Sunba M. S., Rahi A. H., Morgan G., Holborow E. J. Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour. Br J Ophthalmol. 1980 Aug;64(8):576–590. doi: 10.1136/bjo.64.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]